Clinical Research Directory
Browse clinical research sites, groups, and studies.
Are Smokers Switching to Vaping at Lower Risk for Cancer? (Electronic Cigarettes and Cancer Risk)
Sponsor: University of Southern California
Summary
This project will address a growing public health concern, namely, the health risks or benefits of e-cig use relative to cigarette smoking. The investigators will use biomarkers of early effects of relevance to cancer to determine the carcinogenic potential of e-cig use relative to cigarette smoking in oral epithelium, which is a target tissue for smoking-associated cancer. The study population will consist of one group of smokers who are interested in switching to e-cig use (Grp 1), one group of smokers who do not intend to change their smoking habits (Grp 2), and one group of non-users who would like to maintain their nonsmoking non-vaping status (Grp 3); The total number of participants in this project is 150 (n = 50, each group). The investigators will use an integrative 'multi-omics' approach complemented with single-locus/gene validation analyses to detect temporal changes in the genome, epigenome, and transcriptome relevant to cancer in the oral cells of the participants as the intervention progresses.
Official title: Are Smokers Switching to Vaping at Lower Risk for Cancer?
Key Details
Gender
All
Age Range
22 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2021-12-01
Completion Date
2028-07-31
Last Updated
2025-08-06
Healthy Volunteers
Yes
Conditions
Interventions
NIDA Standard Research E-cigarette (SREC)
Smokers will switch to NIDA Standard Research E-cigarette (SREC).
Locations (1)
University of Southern California, Health Sciences Campus
Los Angeles, California, United States